Oncology Institute Inc
NASDAQ:TOI
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Oncology Institute Inc
NASDAQ:TOI
|
US |
|
Kaspien Holdings Inc
OTC:KSPN
|
US |
|
Dynavax Technologies Corp
NASDAQ:DVAX
|
US |
|
Oriental Land Co Ltd
F:OLL
|
JP |
|
Mold-Tek Technologies Ltd
NSE:MOLDTECH
|
IN |
|
R
|
Renewal Fuels Inc
OTC:RNWF
|
US |
|
DSV A/S
F:DS81
|
DK |
|
Greenlight Capital Re Ltd
NASDAQ:GLRE
|
KY |
|
I
|
Intelicanna Ltd
TASE:INTL
|
IL |
|
U
|
Uniphos Enterprises Ltd
NSE:UNIENTER
|
IN |
|
A
|
Air Products and Chemicals Inc
F:AP3
|
US |
|
B
|
Bank of America Corp
SIX:BAC
|
US |
Wall Street
Price Targets
TOI Price Targets Summary
Oncology Institute Inc
According to Wall Street analysts, the average 1-year price target for
TOI
is 7.14 USD
with a low forecast of 5.05 USD and a high forecast of 8.4 USD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is TOI's stock price target?
Price Target
7.14
USD
According to Wall Street analysts, the average 1-year price target for
TOI
is 7.14 USD
with a low forecast of 5.05 USD and a high forecast of 8.4 USD.
What is Oncology Institute Inc's Revenue forecast?
Projected CAGR
28%
For the last 6 years the
compound annual growth rate for
Oncology Institute Inc's revenue is
22%.
The projected
CAGR
for the next 2 years is
28%.
